Ye Ju1, Ailian Liu1, Jiazheng Wang2, Wenjun Hu1, Changyu Du3, Lingli Qi3, Haoyang Jiang3, Xinmiao Bu1, Nan Wang1, and Peng Sun2
1First Affiliated Hospital of Dalian Medical University, Dalian, China, 2Philips Healthcare, Beijing, China, 3Dalian Medical University, Dalian, China
Amide proton transfer (APT) and mDixon - Quant techniques have been applied in clinical work, However, there was no study on the degree of renal damage in chronic kidney disease (CKD). We discussed the value of APT combined with R2* to assess the degree of renal damage. The AUC, sensitivity and specificity of APT combined R2* were 0.925, 88% and 100%, respectively. The combination of APT and R2* can improve the diagnostic ability of discriminating CKD from HVs, which has certain clinical application value.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
